Evaluation of the clinical effect of visualized neuromodulation in the Traditional Chinese Medicine treatment of limb dysfunction in stroke patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR1900002857

Enrollment

Unknown

Registered

2019-12-20

Start date

2019-12-30

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Control group:Basic care

Experimental group:Basic care + visualized neuromodulation technology of Traditional Chinese Medicine

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stroke according to the criteria of both western medicine and confirmed by head CT or MRI with stable vital signs; 2. Patients with stroke according to the criteria of Traditional Chinese Medicine, Aged between 18 and 85 years, cerebral hemorrhage or cerebral infraction for the first time,time since stroke of 2 weeks at least with hemiplegia 3. stable vital signs,no progress within 48 hours,Glasgow Co-ma Scale>8 points; 4. clinical feature is hemiplegia,the UK Medical Research Council between 0 and 3 level; 5. Clear awareness, can cooperate with treatment, can express feelings and follow instructions; 6. Relatively fixed address or telephone number, which can be followed up for a long time; 7. Those who voluntarily participated in the research project and signed the informed consent and the process of obtaining informed consent shall be in accordance with the provisions of GCP.

Exclusion criteria

Exclusion criteria: 1. Patients who could not meet the above standards; 2. Patients with transient ischemic attack, progressive stroke, massive cerebral infarction and massive cerebral hemorrhage; 3. Patients with severe mental disorders; 4. Patients with moderate or above dementia and can notcooperate with treatment; 5. Patients with previous heart tremor, rheumatic heart disease and other diseases that are easy to lead to embolus falling off; 6. Patients with severe heart, liver and kidney dysfunction and shock; 7. Patients with tumor, pregnancy and coagulation disorders.

Design outcomes

Primary

Measure	Time frame
standard motor function test;	—

Secondary

Measure	Time frame
Modified Ashworth Scale;Metabonomics index;activities of daily living;Functional Magnetic Resonance Imaging;clinic neurological function deficit scale;	—

Countries

China

Contacts

Public ContactWu Xiaoliang

81485166@qq.com+86 15805164099

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026